Literature DB >> 25701359

BTG3 upregulation induces cell apoptosis and suppresses invasion in esophageal adenocarcinoma.

Yuwen Du1, Pingping Liu, Wenqiao Zang, Yuanyuan Wang, Xiaonan Chen, Min Li, Guoqiang Zhao.   

Abstract

B cell translocation gene 3 (BTG3) is a tumor suppressor by inhibiting cell proliferation, migration, and regulating cell cycle progression in several tumors. However, its role in esophageal adenocarcinoma (EAC) remains unknown. Here, we detected the expression of BTG3 in EAC tissues and subsequent progression. BTG3 expression was significant decreased in EAC tissues and cell lines detected by real-time RT-PCR and Western blot. Relationships of BTG3 with EAC clinicopathology were analyzed statistically. The decrease expression of BTG3 is associated with lymph node metastases. In vitro assay demonstrated that overexpression of BTG3 significantly suppressed colony formation and proliferation of EAC cells. The suppressed migration and invasion abilities found in BTG3-overexpressing EAC cells. Our findings suggested that BTG3 is suppressor in the progression of EAC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25701359     DOI: 10.1007/s11010-015-2363-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.

Authors:  Alexander D Boiko; Sarah Porteous; Olga V Razorenova; Vadim I Krivokrysenko; Bryan R Williams; Andrei V Gudkov
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

2.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

3.  Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer.

Authors:  X L Ren; X H Zhu; X M Li; Y L Li; J M Wang; P X Wu; Z B Lv; W H Ma; W T Liao; W Wang; Y Q Ding; L Liang
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-20       Impact factor: 4.553

4.  Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.

Authors:  Hirofumi Kawakubo; Elena Brachtel; Tetsu Hayashida; Giminna Yeo; Joshua Kish; Alona Muzikansky; Paul D Walden; Shyamala Maheswaran
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

5.  Downregulation of BTG3 in non-small cell lung cancer.

Authors:  Xiaobing Chen; Guoyong Chen; Xinguang Cao; Yudong Zhou; Tiejun Yang; Sidong Wei
Journal:  Biochem Biophys Res Commun       Date:  2013-06-26       Impact factor: 3.575

6.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

7.  Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.

Authors:  Hironobu Yanagie; Tuyoshi Tanabe; Hidetoshi Sumimoto; Hirotaka Sugiyama; Satoru Matsuda; Yasumasa Nonaka; Naoko Ogiwara; Katsunori Sasaki; Kensaburo Tani; Shinichi Takamoto; Hiroyuki Takahashi; Masazumi Eriguchi
Journal:  Biomed Pharmacother       Date:  2008-06-18       Impact factor: 6.529

Review 8.  The mammalian anti-proliferative BTG/Tob protein family.

Authors:  G Sebastiaan Winkler
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

9.  Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3.

Authors:  Stefano Farioli-Vecchioli; Mirella Tanori; Laura Micheli; Mariateresa Mancuso; Luca Leonardi; Anna Saran; Maria Teresa Ciotti; Elisabetta Ferretti; Alberto Gulino; Simonetta Pazzaglia; Felice Tirone
Journal:  FASEB J       Date:  2007-03-19       Impact factor: 5.191

10.  The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.

Authors:  Zhenbing Lv; Huichun Zou; Kaiwen Peng; Jianmei Wang; Yi Ding; Yuling Li; Xiaoli Ren; Feifei Wang; Rui Chang; Li Liang; Yanqing Ding
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more
  12 in total

1.  KLF12 Regulates Mouse NK Cell Proliferation.

Authors:  Viola C Lam; Lasse Folkersen; Oscar A Aguilar; Lewis L Lanier
Journal:  J Immunol       Date:  2019-07-12       Impact factor: 5.422

2.  Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer.

Authors:  Jingjing Dai; Abdusemer Reyimu; Ao Sun; Zaxi Duoji; Wubi Zhou; Song Liang; Suxia Hu; Weijie Dai; Xiaoguang Xu
Journal:  Sci Rep       Date:  2022-05-14       Impact factor: 4.996

3.  Direct Downregulation of B-Cell Translocation Gene 3 by microRNA-93 Is Required for Desensitizing Esophageal Cancer to Radiotherapy.

Authors:  Hujun Cui; Shengqiang Zhang; Hongbo Zhou; Ling Guo
Journal:  Dig Dis Sci       Date:  2017-04-22       Impact factor: 3.199

4.  The function of BTG3 in colorectal cancer cells and its possible signaling pathway.

Authors:  Chi Lv; Heling Wang; Yuxin Tong; Hongzhuan Yin; Dalu Wang; Zhaopeng Yan; Yichao Liang; Di Wu; Qi Su
Journal:  J Cancer Res Clin Oncol       Date:  2017-12-21       Impact factor: 4.553

5.  The suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study.

Authors:  Hua-Chuan Zheng; Hao-Yu He; Ji-Cheng Wu; Jing Li; Shuang Zhao; Gui-Feng Zhao; Hua-Mao Jiang; Xue-Wen Yu; Zhi-Jie Li
Journal:  Oncotarget       Date:  2017-03-14

6.  iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.

Authors:  Ying Xiong; Fei Sun; Peixin Dong; Hidemichi Watari; Junming Yue; Min-Fei Yu; Chun-Yan Lan; Yin Wang; Ze-Biao Ma
Journal:  J Exp Clin Cancer Res       Date:  2017-04-11

7.  Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Xiang-Yin Kong; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2017-02-14       Impact factor: 3.411

8.  Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral Lactobacillus plantarum.

Authors:  Jianqing Xu; Zhihong Ren; Kangli Cao; Xianping Li; Jing Yang; Xuelian Luo; Lingyan Zhu; Xiangwei Wang; Longfei Ding; Junrong Liang; Dong Jin; Tingting Yuan; Lianfeng Li; Jianguo Xu
Journal:  Front Nutr       Date:  2021-12-22

9.  microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma.

Authors:  Bilegsaikhan Enkhnaran; Guang-Cong Zhang; Ning-Ping Zhang; Hai-Ning Liu; Hao Wu; Shi Xuan; Xiang-Nan Yu; Guang-Qi Song; Xi-Zhong Shen; Ji-Min Zhu; Xiu-Ping Liu; Tao-Tao Liu
Journal:  J Oncol       Date:  2022-03-17       Impact factor: 4.375

10.  Integrated Bioinformatics Analysis Identifies Hub Genes Associated with the Pathogenesis and Prognosis of Esophageal Squamous Cell Carcinoma.

Authors:  Hui Zhang; Jianing Zhong; Youbing Tu; Benquan Liu; Zhibo Chen; Yunchen Luo; Yaping Tang; Fei Xiao; Jincai Zhong
Journal:  Biomed Res Int       Date:  2019-12-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.